The clinical application of QuantiFERON TB-2G: Its usefulness and limitations

Kekkaku

Volumn 86, Issue 2, 2011, Pages 101-112

  Sato, Shigeki ^a   Nagai, Hideaki ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b TOKYO NATIONAL HOSPITAL   (Japan)

Author keywords

Immunosuppression; Interferon ; QuantiFERON 2G (QFT); TNF; Transplant; Tuberculosis

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; DRUG ANTAGONISM; HUMAN; IMMUNOCOMPROMISED PATIENT; KIDNEY TRANSPLANTATION; LATENT TUBERCULOSIS; RHEUMATOID ARTHRITIS; TUBERCULOSIS;

ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOCOMPROMISED HOST; INTERFERON-GAMMA; KIDNEY TRANSPLANTATION; LATENT TUBERCULOSIS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855523759     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Fishman JA: Infection in solid-organ transplant recipients. N Engl J Med. 2007; 357 : 2601- 2614.
2. Kasiske BL., Cangro CB., Hariharan S., et al.: The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant. 2001 : 1 Suppl 2 : .V 95.
3. Muñoz P., Rodriguez C., Bouza E: Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis. 2005; 40 : 581- 587.
4. Kobasln Y., Mouri K., Obase Y, et al.: Clinical evaluation of QuantiFFKON TB-2G test lor imniunoconiprontised patients. Eur Respir J. 2007 : 50 : 945 -950.
5. Kang YA., Lee HW, Yoon HI., et al.: Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay lor the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden countiy JAMA. 2005;293, 2756-61.
6. Winthrop KL., Nyenda M, Calvet H., et al.: Imerlcron-siamnia release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol. 2008 : 3 : 1357-1363.
7. Thomas PA Jr., Mozes MR, Jonasson O: Hepatic dysfunction during isoniazid chemoprophylaxis in renal allograft recipients. Arch Surg. 1979; 114 : 597-599.
8. Uarada N, Higuchi K, Yoshiyama T, et al.: Comparison of the sensitivity and specificity of two whole blood interferon- gamma assays for M. tuberculosis infection. J Infect. 2008; 56 : 348-353.
9. Smolen JS., Aletaha D., Bijlsmu JW., et al.: Treating rheuma toid arthritic to target: recommendations of an international task force. Ann Rheum Dis. 2011: 69 : 631- 637.
10. VlaedaT, Banno S. Maeda S., el al.: Usefulness and limitations of (JuantiFFRON-I B Gold in Japanese rheumatoid arthritis patients: Proposal to decrease the lower cutoff level for assessing latent tuberculosis infection. Mod Rheumatol. 2010; 20 : 18 -23.
11. Kohashi Y, Mouri K., Yagi S, et al.: Transitional changes to in T-cell responses to Mycobacterium tuberculosis-specitic antigens during treatment. J Infect. 2009 : 58 : 197 -204.